A detailed history of Eagle Bay Advisors LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 71 shares of CTLT stock, worth $4,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71
Previous 113 37.17%
Holding current value
$4,235
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$56.16 - $60.96 $2,358 - $2,560
-42 Reduced 37.17%
71 $4,000
Q2 2024

Jul 26, 2024

SELL
$53.58 - $57.02 $3,536 - $3,763
-66 Reduced 36.87%
113 $6,000
Q1 2024

May 08, 2024

SELL
$42.56 - $59.82 $1,276 - $1,794
-30 Reduced 14.35%
179 $10,000
Q4 2023

Feb 08, 2024

SELL
$32.18 - $46.57 $46,596 - $67,433
-1,448 Reduced 87.39%
209 $9,000
Q3 2023

Nov 13, 2023

BUY
$44.2 - $50.2 $21,392 - $24,296
484 Added 41.26%
1,657 $75,000
Q2 2023

Aug 10, 2023

SELL
$31.86 - $67.26 $4,715 - $9,954
-148 Reduced 11.2%
1,173 $50,000
Q1 2023

Apr 24, 2023

BUY
$45.44 - $74.26 $3,044 - $4,975
67 Added 5.34%
1,321 $86,000
Q4 2022

Jan 26, 2023

BUY
$41.39 - $81.0 $30,173 - $59,049
729 Added 138.86%
1,254 $0
Q3 2022

Nov 22, 2022

SELL
$72.36 - $113.1 $69,031 - $107,897
-954 Reduced 64.5%
525 $39,000
Q2 2022

Aug 19, 2022

BUY
$87.2 - $114.05 $84,409 - $110,400
968 Added 189.43%
1,479 $159 Million
Q1 2022

May 11, 2022

SELL
$94.19 - $124.49 $34,285 - $45,314
-364 Reduced 41.6%
511 $57,000
Q4 2021

Jan 21, 2022

BUY
$119.57 - $139.07 $11,120 - $12,933
93 Added 11.89%
875 $112,000
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $15,392 - $20,071
-141 Reduced 15.28%
782 $105,000
Q2 2021

Jul 30, 2021

BUY
$100.34 - $115.69 $92,613 - $106,781
923 New
923 $102,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.7B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.